Summary
Neurofibromatosis is sometimes complicated by impaired renal tubular reabsorption of phosphate, hypophosphatemia, and osteomalacia. Hyperparathyroidism has also been reported in patients with neurofibromatosis. When hypercalcemia and elevated levels of parathyroid hormone are found in osteomalacia, however, it may be difficult to determine if the hyperparathyroidism was primary or tertiary. We describe a patient with neurofibromatosis, hypercalcemic hyperparathyroidism, hypophosphatemic osteomalacia, vitamin D deficiency, and clear-cell hyperplasia of all four parathyroid glands. Serial biomechanical, bone biopsy, and densitometric studies confirmed that treatment with ergocalciferol, calcium, and phosphate supplements significantly improved the osteomalacia but caused increased parathyroid overactivity. After subtotal parathyroidectomy, the parathyroid hormone concentration became normal and the bone mineral content increased at the spine and hip, but inappropriate phosphaturia persisted. The findings indicate that hyperparathyroidism, osteomalacia, and vitamin D deficiency adversely affect each other.
Similar content being viewed by others
References
Riccardi VM (1981) Von Recklinghausen neurofibromatosis. N Engl J Med 305:1617–1627
Albright F, Reifenstein EC (1948) Clinical hyperparathyroidism. In: The parathyroid glands and metabolic bone disease. Williams and Wilkins, Baltimore, pp 64–121
Cohen R, Douady D (1936) Coexistence des deux maladies de Reckinghausen chez un sujet. Presse Medicale 102:2063–2064
Thannhauser SJ (1944) Neurofibromatosis (von Recklinghausen) and osteitis fibrosa cystica localisata et disseminata (von Recklinghausen). Medicine 23:105–148
Clark DH, Lumberton NC, Mathews WR (1953) Simultaneous occurrence of von Recklinghausen's neurofibromatosis and osteitis fibrosa cystica. Surgery 33:434–443
Foukas M, Skouteris A (1966) Uber das zusammentreffen von morbus Recklinghausen, hyperparathyreoidismus und Graviditat. Zentralbl Gynakol 88:999–1006
Daly D, Kaye M, Estrada RL (1970) Neurofibromatosis and hyperparathyroidism—a new syndrome? Can Med Assoc J 103:258–259
Dawkins RL, Tashjian AH, Castleman B, Moore EW (1973) Hyperparathyroidism due to clear-cell hyperplasia. Am J Med 54:119–126
Holt JF (1978) Neurofibromatosis in children. Am J Roentgenol 130:615–639
Chakrabarti S, Murugesan A, Arida EJ (1979) The association of neurofibromatosis and hyperparathyroidism. Am J Surg 137:417–420
Freimanis MG, Rodgers RW, Samaan NA (1984) Neurofibromatosis and hyperparathyroidism. South Med J 77:794–795
Hoppe LB, Collicott PE, Stivrins TJ (1986) Von Recklinghausen's neurofibromatosis and hyperparathyroidism: a case report and literature review. Nebraska Med J 71:435–437
Gould EP (1918) The bone changes occurring in von Recklinghausen's disease. Q J Med 11:221–230
Stalmann A (1933) Nerven-, haut- und knochenveranderungen bei der neurofibromatosis Recklinghausen und ihre entstehungsgeschichtlichen zusammenhange. Virchows Arch F Path Anat 289:96–126
Merklen P, Israel L (1934) Maladie de Recklinghausen avec lesions osseuses multiples. Paris Med 1:411–412
Norgaard F (1937) Osseous changes in Recklinghausen's neurofibromatosis. Acta Radiol 18:460–470
Hagelstam L (1946) On the deformities of the spine in multiple neurofibromatosis (von Recklinghausen). Acta Chir Scand 93:169–193
Hernberg CA, Edgren W (1949) Looser-Milkman's syndrome with neurofibromatosis Recklinghausen and generalized decalcification of the skeleton. Acta Med Scand 136:26–33
Dent CE (1952) Rickets and osteomalacia from renal tubule defects. J Bone Joint Surg 34B:266–274
Nordin BEC, Fraser R (1953) Vitamin D-resistant osteomalacia associated with neurofibromatosis. Proc Royal Soc Med 46:302–304
Swann GF (1954) Pathogenesis of bone lesions in neurofibromatosis. Br Med J 27:623–629
Saville PD, Nassim JR, Stevenson FH, Mulligan L, Carey M (1955) Osteomalacia in von Recklinghausen's neurofibromatosis. Br Med J 1:1311–1313
Levene LJ (1959) Bone changes in neurofibromatosis. Arch Intern Med 103:570–580
Balsan S, Guivarch J, Darois AM, Royer P (1967) Rachitisme vitamine-resistant associe a une neurofibromatose probable chez un enfant. Arch Fr Pediatr 24:609–632
Dent CE (1976) Metabolic forms of rickets (and osteomalacia). In: Bickle H, Stern J (eds) Inborn errors of calcium and bone metabolism, University Park Press, Baltimore, pp 124–149
Retnam VJ, Rangnekar DM, bhandarkar SD (1980) Neurofibromatosis with hypophosphatemic osteomalacia (von Recklinghausen- Hernberg-Edgren-Swann syndrome): a case report. J Assoc Physicians India 28:319–322
Wattiaux MJ, De Vernejoul MC, Bletry O, Ulmann A, Rondier J, Godeau P (1985) Maladie de Recklinghausen avec hypophosphoremie et osteomalacie. Rev Med Interne 6:495–502
Hogan DB, Anderson C, Mackenzie RA, Crilly RG (1986) Hypophosphatemic osteomalacia complicating von Recklinghausen's neurofibromatosis: increase in spinal density on treatment. Bone 7:9–12
Snapper I (1957) Neurofibromatosis of bone. In: Bone diseases in medical practice. Grune and Stratton, New York, pp 180–181
Reid IR, Teitelbaum SL, Dusso A, Whyte MP (1987) Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia: effect of successful tumor resection on mineral homeostasis. Am J Med 83:350–354
Davies DR, Dent CE, Watson L (1968) Tertiary hyperparathyroidism. Br Med J 2:395–399
Castleman B, Roth SI (1978) Tumors of the parathyroid glands. Armed Forces Institute of Pathology, Washington, pp 67–74
Walton RJ, Bijvoet OLM (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309–310
Weinstein RS, Bryce GF, Sappington LJ, King DW, Gallagher BB (1984) Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 58:1003–1009
Weinstein RS, Bell NH (1988) Diminished rate of bone formation in normal black adults. N Engl J Med 319:1689–1701
Weinstein RS, Sappington LJ (1982) Qualitative bone defect in uremic osteosclerosis. Metabolism 31:805–811
Mixter CG, Keynes WM, Cope O (1962) Further experience with pancreatitis as a diagnostic clue to hyperparathyroidism. N Engl J Med 266:265–272
Parfitt AM, Rao DS, Stanciu J, Villanueva AR, Kleerekoper M, Frame B (1985) Irreversible bone loss in osteomalacia. J Clin Invest 76:2403–2412
Kleeman CR, Norris K, Coburn JW (1987) Is the clinical expression of primary hyperparathyroidism a function of the long-term vitamin D status of the patient? Miner Electrolyte Metab 13:305–310
Clements MR, Johnson L, Fraser DR (1987) A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 325:62–65
Firth RG, Grant CS, Riggs BL (1985) Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Am J Med 78:669–673
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weinstein, R.S., Harris, R.L. Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis. Calcif Tissue Int 46, 361–366 (1990). https://doi.org/10.1007/BF02554965
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02554965